Malignant Neck Neoplasm — Trials

Malignant Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 607
Recruiting: 330
Ph III recruiting: 76
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: Sun Yat-sen University
Termination share: 27.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 151–200 of 802 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05111574	Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery	active not recruiting	Phase 2	101	National Cancer Institute (NCI)NIH	2	Aug 4, 2026	clinicaltrials
NCT07713901	Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma	enrolling by invitation	—	93,600,000	Novo Nordisk A/SINDUSTRY	1	Aug 4, 2026	clinicaltrials